Identification of Frame Neoantigens to Develop Highly Immunogenic Cancer Vaccines

Time: 2:00 pm
day: Track A - Day 1 PM


  • Identifying Frame neoantigens derived from neo-open reading frames in human cancers identification of all neoantigens resulting from SVs and subsequent RNA splicing
  • Utilising a unique combination of tumour sequencing technologies for comprehensive detection of neoantigens at high sensitivity
  • Demonstrating pre-clinical proof of the overwhelming immunogenicity of Frame neoantigens